Sanofi defeats government’s $325M appeal over generic Plavix ban

Appeals 2023-06-26 4:00 pm By Cindy Cameronne | Sydney

Please login to bookmark

Drug maker Sanofi-Aventis is not liable for the federal government’s losses for excess subsidies paid for the blood-thinner Plavix after an allegedly unjustified court injunction prevented the release of a generic version of the blockbuster drug, an appeals court has found.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au